Variations in aggrecan structure modulate its susceptibility to aggrecanases
- 1 October 2003
- journal article
- Published by Portland Press Ltd. in Biochemical Journal
- Vol. 375 (1) , 183-189
- https://doi.org/10.1042/bj20030609
Abstract
Proteoglycan aggregates and purified aggrecan from adult and fetal bovine cartilage and adult and neonatal human cartilage were subjected to in vitro degradation by recombinant aggrecanase-1 and aggrecanase-2. The ability of the aggrecanases to cleave within the aggrecan IGD (interglobular domain) and CS2 domain (chondroitin sulphate-rich domain 2) was monitored by SDS/PAGE and immunoblotting. Aggrecanase-2 showed a similar ability to cleave within the IGD of adult and immature aggrecan, whereas aggrecanase-1 was less efficient in cleavage in the IGD of immature aggrecan, for both the bovine and the human substrates. Both aggrecanases showed a similar ability to cleave within the CS2 domain of bovine aggrecan irrespective of age, but showed a much lower ability to cleave within the CS2 domain of human aggrecan. Equivalent results were obtained whether aggrecan was present in isolation or as part of proteoglycan aggregates. When proteoglycan aggregates were used, neither aggrecanase was able to cleave link protein. Thus, for aggrecan cleavage by aggrecanases, variations in cleavage efficiency exist with respect to the species and age of the animal from which the aggrecan is derived and the type of aggrecanase being used.Keywords
This publication has 40 references indexed in Scilit:
- Inhibition of ADAM-TS4 and ADAM-TS5 Prevents Aggrecan Degradation in Osteoarthritic CartilageJournal of Biological Chemistry, 2002
- ADAMTS4 Cleaves at the Aggrecanase Site (Glu373-Ala374) and Secondarily at the Matrix Metalloproteinase Site (Asn341-Phe342) in the Aggrecan Interglobular DomainJournal of Biological Chemistry, 2002
- ADAMTS1 cleaves aggrecan at multiple sites and is differentially inhibited by metalloproteinase inhibitorsBiochemical and Biophysical Research Communications, 2002
- Cloning and Characterization of ADAMTS-14, a Novel ADAMTS Displaying High Homology with ADAMTS-2 and ADAMTS-3Journal of Biological Chemistry, 2002
- Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpuraNature, 2001
- Keratan sulfate disaccharide composition determined by FACE analysis of keratanase II and endo- -galactosidase digestion productsGlycobiology, 2001
- Analysis of aggrecan in human knee cartilage and synovial fluid indicates that aggrecanase (ADAMTS) activity is responsible for the catabolic turnover and loss of whole aggrecan whereas other protease activity is required for C-terminal processing in vivoBiochemical Journal, 2001
- Procollagen II Amino Propeptide Processing by ADAMTS-3Journal of Biological Chemistry, 2001
- Versican V1 Proteolysis in Human Aorta in Vivo Occurs at the Glu441-Ala442 Bond, a Site That Is Cleaved by Recombinant ADAMTS-1 and ADAMTS-4Journal of Biological Chemistry, 2001
- Cloning and Characterization of ADAMTS11 , an Aggrecanase from the ADAMTS FamilyJournal of Biological Chemistry, 1999